Nurix Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRIX and other ETFs, options, and stocks.About NRIX
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases.
CEOArthur T. Sands
CEOArthur T. Sands
Employees286
Employees286
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2009
Founded2009
Employees286
Employees286
NRIX Key Statistics
Market cap975.05M
Market cap975.05M
Price-Earnings ratio-4.55
Price-Earnings ratio-4.55
Dividend yield—
Dividend yield—
Average volume990.39K
Average volume990.39K
High today$13.13
High today$13.13
Low today$12.69
Low today$12.69
Open price$12.82
Open price$12.82
Volume1.05M
Volume1.05M
52 Week high$29.56
52 Week high$29.56
52 Week low$8.18
52 Week low$8.18
Analyst ratings
89%
of 18 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own NRIX. This list is generated using Robinhood data, and it’s not a recommendation.